{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:38:13Z","timestamp":1790098693662,"version":"4.0.1"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Curcumin is the main active constituent of the medicinal plant Curcuma longa L., used\ntraditionally as a medicinal spice in several ancient civilizations. Different preclinical and clinical\nstudies support the anti-inflammatory properties of curcumin in various inflammatory diseases. As\ninflammation has an essential role in the pathophysiology of many ocular diseases, curcumin has\nbeen suggested as a promising therapeutic agent with anti-inflammatory properties. Based on the\nextent of experimental and clinical evidence, curcumin can exert protective effects against the\ncorneal, uveal, retinal, optic nerve, orbital, and lacrimal gland inflammatory disorders. Herein, the\navailable literature on the beneficial effects of curcumin in inflammatory eye diseases is reviewed.\nThe limitations and future directions of these investigations are also discussed.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201023666220609085614","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T06:13:39Z","timestamp":1655100819000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Implications of Curcumin in the Treatment of Inflammatory\nEye Diseases: A Review"],"prefix":"10.2174","volume":"24","author":[{"given":"Muthu","family":"Thiruvengadam","sequence":"first","affiliation":[{"name":"Department of Applied Bioscience, College of Life and\nEnvironmental Sciences, Konkuk University, Seoul, 05029, Korea"},{"name":"Department of Microbiology, Saveetha Dental\nCollege, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Heydari","sequence":"additional","affiliation":[{"name":"Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of\nMedical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Khalili","sequence":"additional","affiliation":[{"name":"Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of\nMedical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nowroozzadeh","sequence":"additional","affiliation":[{"name":"Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of\nMedical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Bamdad","sequence":"additional","affiliation":[{"name":"Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of\nMedical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad\nUniversity of Medical Sciences, Mashhad, Iran"},{"name":"Applied Biomedical Research Center, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Shariati","sequence":"additional","affiliation":[{"name":"K.G. Razumovsky Moscow State University of Technologies and Management (the First\nCossack University), Moscow 109004, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Prasad S.","year":"2011","unstructured":"Prasad S.; Aggarwal B.B.; Turmeric, the golden spice: From Traditional Medicine to Modern Medicine. In: Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed; In: Benzie IFF, Wachtel- Galor S, editors. CRC Press\/Taylor and Francis: Boca Raton (FL), 2011"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.47947\/ijnls.736452","volume":"4","author":"Satil F.","year":"2020","unstructured":"Satil F.; Mikail A.; Ethnobotanical use of Stachys L. (Lamiaceae) taxa in Turkey. Int J Nat Life Sci 2020,4(2),66-86","journal-title":"Int J Nat Life Sci"},{"key":"ref=3","first-page":"141","volume":"14","author":"Jurenka J.S.","year":"2009","unstructured":"Jurenka J.S.; Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009,14(2),141-153","journal-title":"Altern Med Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1016\/j.bmc.2004.05.006","volume":"12","author":"Adams B.K.","year":"2004","unstructured":"Adams B.K.; Ferstl E.M.; Davis M.C.; Herold M.; Kurtkaya S.; Camalier R.F.; Hollingshead M.G.; Kaur G.; Sausville E.A.; Rickles F.R.; Snyder J.P.; Liotta D.C.; Shoji M.; Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem 2004,12(14),3871-3883","journal-title":"Bioorg Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"Menon V.P.","year":"2007","unstructured":"Menon V.P.; Sudheer A.R.; Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 2007,595,105-125","journal-title":"Adv Exp Med Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.lfs.2004.11.039","volume":"77","author":"Zahid Ashraf M.","year":"2005","unstructured":"Zahid Ashraf M.; Hussain M.E.; Fahim M.; Antiatherosclerotic effects of dietary supplementations of garlic and turmeric: Restoration of endothelial function in rats. Life Sci 2005,77(8),837-857","journal-title":"Life Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5567\/sciintl.2013.57.63","volume":"1","author":"Kaur G.","year":"2013","unstructured":"Kaur G.; Meena C.; Evaluation of anti-hyperlipidemic potential of combinatorial extract of curcumin, piperine and quercetin in Triton-induced hyperlipidemia in rats. Sci Int 2013,1(3),57-63","journal-title":"Sci Int"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/678218","volume":"2015","author":"Gutierres V.O.","year":"2015","unstructured":"Gutierres V.O.; Campos M.L.; Arcaro C.A.; Assis R.P.; Baldan-Cimatti H.M.; Peccinini R.G.; Paula-Gomes S.; Kettelhut I.C.; Baviera A.M.; Brunetti I.L.; Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evid Based Complement Alternat Med 2015,2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107600","volume":"96","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Wang Y.; Cai N.; Xu T.; He F.; Anti-inflammatory effects of curcumin in acute lung injury: In vivo and in vitro experimental model studies. Int Immunopharmacol 2021,96","journal-title":"Int Immunopharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112123","volume":"151","author":"Wang C.","year":"2021","unstructured":"Wang C.; Han Z.; Wu Y.; Lu X.; Tang X.; Xiao J.; Li N.; Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system. Food Chem Toxicol 2021,151","journal-title":"Food Chem Toxicol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12906-021-03207-3","volume":"21","author":"Rinkunaite I.","year":"2021","unstructured":"Rinkunaite I.; Simoliunas E.; Alksne M.; Dapkute D.; Bukelskiene V.; Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats. BMC Complement Med Ther 2021,21(1),39","journal-title":"BMC Complement Med Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/pharmaceutics13040484","volume":"13","author":"Karthikeyan A.","year":"2021","unstructured":"Karthikeyan A.; Young K.N.; Moniruzzaman M.; Beyene A.M.; Do K.; Kalaiselvi S.; Min T.; Curcumin and its modified formulations on Inflammatory Bowel Disease (IBD): The story so far and future outlook. Pharmaceutics 2021,13(4),484","journal-title":"Pharmaceutics"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105743","volume":"160","author":"Mohan M.","year":"2021","unstructured":"Mohan M.; Hussain M.A.; Khan F.A.; Anindya R.; Symmetrical and un-symmetrical curcumin analogues as selective COX-1 and COX-2 inhibitor. Eur J Pharm Sci 2021,160","journal-title":"Eur J Pharm Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4103\/1673-5374.295339","volume":"16","author":"Gutierrez M.E.Z.","year":"2021","unstructured":"Gutierrez M.E.Z.; Savall A.S.P.; da Luz Abreu E.; Nakama K.A.; Dos Santos R.B.; Guedes M.C.M.; &#xC1;vila D.S.; Luchese C.; Haas S.E.; Quines C.B.; Pinton S.; Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice. Neural Regen Res 2021,16(4),783-789","journal-title":"Neural Regen Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1080\/07391102.2020.1800513","volume":"39","author":"Mirzaei M.","year":"2021","unstructured":"Mirzaei M.; Harismah K.; Soleimani M.; Mousavi S.; Inhibitory effects of curcumin on aldose reductase and cyclooxygenase-2 enzymes. J Biomol Struct Dyn 2021,39(17),6424-6430","journal-title":"J Biomol Struct Dyn"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/08830185.2012.737877","volume":"32","author":"Niederkorn J.Y.","year":"2013","unstructured":"Niederkorn J.Y.; Corneal transplantation and immune privilege. Int Rev Immunol 2013,32(1),57-67","journal-title":"Int Rev Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22336\/rjo.2019.4","volume":"63","author":"Sharif Z.","year":"2019","unstructured":"Sharif Z.; Sharif W.; Corneal neovascularization: Updates on pathophysiology, investigations and management. Rom J Ophthalmol 2019,63(1),15-22","journal-title":"Rom J Ophthalmol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00109-015-1277-z","volume":"93","author":"Pradhan N.","year":"2015","unstructured":"Pradhan N.; Guha R.; Chowdhury S.; Nandi S.; Konar A.; Hazra S.; Curcumin nanoparticles inhibit corneal neovascularization. J Mol Med 2015,93(10),1095-1106","journal-title":"J Mol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000126081","volume":"222","author":"Bian F.","year":"2008","unstructured":"Bian F.; Zhang M.C.; Zhu Y.; Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Ophthalmologica 2008,222(3),178-186","journal-title":"Ophthalmologica"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"29753","DOI":"10.1038\/srep29753","volume":"6","author":"Guo C.","year":"2016","unstructured":"Guo C.; Li M.; Qi X.; Lin G.; Cui F.; Li F.; Wu X.; Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice. Sci Rep 2016,6(1),29753","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","volume":"123","author":"Dick A.D.","year":"2016","unstructured":"Dick A.D.; Tundia N.; Sorg R.; Zhao C.; Chao J.; Joshi A.; Skup M.; Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology 2016,123(3),655-662","journal-title":"Ophthalmology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.168.5.2483","volume":"168","author":"Foxman E.F.","year":"2002","unstructured":"Foxman E.F.; Zhang M.; Hurst S.D.; Muchamuel T.; Shen D.; Wawrousek E.F.; Chan C.C.; Gery I.; Inflammatory mediators in uveitis: Differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol 2002,168(5),2483-2492","journal-title":"J Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3121\/cmr.4.4.248","volume":"4","author":"van Laar J.A.","year":"2006","unstructured":"van Laar J.A.; van Hagen P.M.; Cytokines in uveitis. Clin Med Res 2006,4(4),248-249","journal-title":"Clin Med Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1167\/iovs.07-1186","volume":"49","author":"Gupta S.K.","year":"2008","unstructured":"Gupta S.K.; Agarwal R.; Srivastava S.; Agarwal P.; Agrawal S.S.; Saxena R.; Galpalli N.; The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits. Invest Ophthalmol Vis Sci 2008,49(9),4036-4040","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=25","first-page":"1201","volume":"4","author":"Allegri P.","year":"2010","unstructured":"Allegri P.; Mastromarino A.; Neri P.; Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol 2010,4,1201-1206","journal-title":"Clin Ophthalmol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1099-1573(199906)13:4<318:AID-PTR445>3.0.CO;2-7","volume":"13","author":"Lal B.","year":"1999","unstructured":"Lal B.; Kapoor A.K.; Asthana O.P.; Agrawal P.K.; Prasad R.; Kumar P.; Srimal R.C.; Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 1999,13(4),318-322","journal-title":"Phytother Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/IIO.0000000000000073","volume":"55","author":"Knickelbein J.E.","year":"2015","unstructured":"Knickelbein J.E.; Chan C.C.; Sen H.N.; Ferris F.L.; Nussenblatt R.B.; Inflammatory mechanisms of age-related macular degeneration. Int Ophthalmol Clin 2015,55(3),63-78","journal-title":"Int Ophthalmol Clin"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"Kauppinen A.","year":"2016","unstructured":"Kauppinen A.; Paterno J.J.; Blasiak J.; Salminen A.; Kaarniranta K.; Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci 2016,73(9),1765-1786","journal-title":"Cell Mol Life Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/eye.2010.196","volume":"25","author":"Wang Y.","year":"2011","unstructured":"Wang Y.; Wang V.M.; Chan C.C.; The role of anti-inflammatory agents in Age-related Macular Degeneration (AMD) treatment. Eye 2011,25(2),127-139","journal-title":"Eye"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10792-018-0845-y","volume":"39","author":"Peddada K.V.","year":"2019","unstructured":"Peddada K.V.; Brown A.; Verma V.; Nebbioso M.; Therapeutic potential of curcumin in major retinal pathologies. Int Ophthalmol 2019,39(3),725-734","journal-title":"Int Ophthalmol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.taap.2013.07.029","volume":"272","author":"Li Y.","year":"2013","unstructured":"Li Y.; Zou X.; Cao K.; Xu J.; Yue T.; Dai F.; Zhou B.; Lu W.; Feng Z.; Liu J.; Curcumin analog 1, 5-bis (2-trifluoromethyl-phenyl)-1, 4-pentadien-3-one exhibits enhanced ability on Nrf2 activation and protection against acrolein-induced ARPE-19 cell toxicity. Toxicol Appl Pharmacol 2013,272(3),726-735","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"Ahmed S.M.U.","year":"2017","unstructured":"Ahmed S.M.U.; Luo L.; Namani A.; Wang X.J.; Tang X.; Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis 2017,1863(2),585-597","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"17295","DOI":"10.1002\/jcp.28347","volume":"234","author":"Bucolo C.","year":"2019","unstructured":"Bucolo C.; Drago F.; Maisto R.; Romano G.L.; D\u2019Agata V.; Maugeri G.; Giunta S.; Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1\/2-mediated activation of the Nrf2\/HO-1 pathway. J Cell Physiol 2019,234(10),17295-17304","journal-title":"J Cell Physiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/ijms19040942","volume":"19","author":"R&#xFC;bsam A.","year":"2018","unstructured":"R&#xFC;bsam A.; Parikh S.; Fort P.E.; Role of inflammation in diabetic retinopathy. Int J Mol Sci 2018,19(4),942","journal-title":"Int J Mol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2014\/502174","volume":"2014","author":"Chalam K.V.","year":"2014","unstructured":"Chalam K.V.; Grover S.; Sambhav K.; Balaiya S.; Murthy R.K.; Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration. J Ophthalmol 2014,2014,6","journal-title":"J Ophthalmol"},{"key":"ref=36","first-page":"194","volume":"5","author":"Aldebasi Y.H.","year":"2013","unstructured":"Aldebasi Y.H.; Aly S.M.; Rahmani A.H.; Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol 2013,5(4),194-202","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/jop.2010.0123","volume":"27","author":"Gupta S.K.","year":"2011","unstructured":"Gupta S.K.; Kumar B.; Nag T.C.; Agrawal S.S.; Agrawal R.; Agrawal P.; Saxena R.; Srivastava S.; Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011,27(2),123-130","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=38","first-page":"3617","volume":"22","author":"Mazzolani F.","year":"2018","unstructured":"Mazzolani F.; Togni S.; Giacomelli L.; Eggenhoffner R.; Franceschi F.; Oral administration of a curcumin-phospholipid formulation (Meriva&#xAE;) for treatment of chronic diabetic macular edema: A pilot study. Eur Rev Med Pharmacol Sci 2018,22(11),3617-3625","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.592274","volume":"11","author":"Filippelli M.","year":"2021","unstructured":"Filippelli M.; Campagna G.; Vito P.; Zotti T.; Ventre L.; Rinaldi M.; Bartollino S.; dell\u2019Omo R.; Costagliola C.; Anti-inflammatory effect of curcumin, homotaurine, and vitamin D3 on human vitreous in patients with diabetic retinopathy. Front Neurol 2021,11","journal-title":"Front Neurol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","volume":"58","author":"Vohra R.","year":"2013","unstructured":"Vohra R.; Tsai J.C.; Kolko M.; The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol 2013,58(4),311-320","journal-title":"Surv Ophthalmol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","volume":"14","author":"Adornetto A.","year":"2019","unstructured":"Adornetto A.; Russo R.; Parisi V.; Neuroinflammation as a target for glaucoma therapy. Neural Regen Res 2019,14(3),391-394","journal-title":"Neural Regen Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1167\/iovs.16-19153","volume":"57","author":"Yang X.","year":"2016","unstructured":"Yang X.; Hondur G.; Tezel G.; Antioxidant treatment limits neuroinflammation in experimental glaucoma. Invest Ophthalmol Vis Sci 2016,57(4),2344-2354","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"11066","DOI":"10.1038\/s41598-018-29393-8","volume":"8","author":"Davis B.M.","year":"2018","unstructured":"Davis B.M.; Pahlitzsch M.; Guo L.; Balendra S.; Shah P.; Ravindran N.; Malaguarnera G.; Sisa C.; Shamsher E.; Hamze H.; Noor A.; Sornsute A.; Somavarapu S.; Cordeiro M.F.; Topical curcumin nanocarriers are neuroprotective in eye disease. Sci Rep 2018,8(1),11066","journal-title":"Sci Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1016\/j.jchemneu.2021.101932","volume":"113","year":"2021","unstructured":"&#x15E;ahin, \u0130.O. How curcumin affects hyperglycemia-induced optic nerve damage: A short review. J Chem Neuroanat 2021,113,101932","journal-title":"J Chem Neuroanat"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10799893.2020.1720240","volume":"40","author":"&#xD6;zkaya D.","year":"2020","unstructured":"&#xD6;zkaya D.; Naz\u0131ro&#x11F;lu, M. Curcumin diminishes cisplatin-induced apoptosis and mitochondrial oxidative stress through inhibition of TRPM2 channel signaling pathway in mouse optic nerve. J Recept Signal Transduct Res 2020,40(2),97-108","journal-title":"J Recept Signal Transduct Res"},{"key":"ref=46","first-page":"543","volume":"3","author":"Bothun E.D.","year":"2009","unstructured":"Bothun E.D.; Scheurer R.A.; Harrison A.R.; Lee M.S.; Update on thyroid eye disease and management. Clin Ophthalmol 2009,3,543-551","journal-title":"Clin Ophthalmol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1365-2249.2002.01792.x","volume":"127","author":"Ludgate M.","year":"2002","unstructured":"Ludgate M.; Baker G.; Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002,127(2),193-198","journal-title":"Clin Exp Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1089\/thy.2007.0407","volume":"18","author":"Lehmann G.M.","year":"2008","unstructured":"Lehmann G.M.; Feldon S.E.; Smith T.J.; Phipps R.P.; Immune mechanisms in thyroid eye disease. Thyroid 2008,18(9),959-965","journal-title":"Thyroid"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1167\/iovs.19-27376","volume":"60","author":"Lee J.S.","year":"2019","unstructured":"Lee J.S.; Kim J.; Lee E.J.; Yoon J.S.; Therapeutic effect of curcumin, a plant polyphenol extracted from Curcuma longae, in fibroblasts from patients with graves\u2019 orbitopathy. Invest Ophthalmol Vis Sci 2019,60(13),4129-4140","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/412158","volume":"2014","author":"Pawlowski P.","year":"2014","unstructured":"Pawlowski P.; Reszec J.; Eckstein A.; Johnson K.; Grzybowski A.; Chyczewski L.; Mysliwiec J.; Markers of inflammation and fibrosis in the orbital fat\/connective tissue of patients with Graves\u2019 orbitopathy: Clinical implications. Mediators Inflamm 2014,2014","journal-title":"Mediators Inflamm"},{"key":"ref=51","first-page":"927","volume":"19","author":"Tsai C.C.","year":"2013","unstructured":"Tsai C.C.; Wu S.B.; Kao S.C.; Kau H.C.; Lee F.L.; Wei Y.H.; The protective effect of antioxidants on orbital fibroblasts from patients with Graves\u2019 ophthalmopathy in response to oxidative stress. Mol Vis 2013,19,927-934","journal-title":"Mol Vis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3390\/ijms22136829","volume":"22","author":"Yu W.K.","year":"2021","unstructured":"Yu W.K.; Hwang W.L.; Wang Y.C.; Tsai C.C.; Wei Y.H.; Curcumin suppresses TGF-&#x3B2;1-induced myofibroblast differentiation and attenuates angiogenic activity of orbital fibroblasts. Int J Mol Sci 2021,22(13),6829","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","volume":"17","author":"Stern M.E.","year":"1998","unstructured":"Stern M.E.; Beuerman R.W.; Fox R.I.; Gao J.; Mircheff A.K.; Pflugfelder S.C.; The pathology of dry eye: The interaction between the ocular surface and lacrimal glands. Cornea 1998,17(6),584-589","journal-title":"Cornea"},{"key":"ref=54","first-page":"14","volume":"12","author":"Wilson S.E.","year":"2003","unstructured":"Wilson S.E.; Inflammation: A unifying theory for the origin of dry eye syndrome. Manag Care 2003,12(12)(Suppl.),14-19","journal-title":"Manag Care"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ophtha.2017.08.029","volume":"124","author":"Rhee M.K.","year":"2017","unstructured":"Rhee M.K.; Mah F.S.; Inflammation in dry eye disease: How do we break the cycle? Ophthalmology 2017,124(11S),S14-S19","journal-title":"Ophthalmology"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/bjo.68.9.674","volume":"68","author":"Damato B.E.","year":"1984","unstructured":"Damato B.E.; Allan D.; Murray S.B.; Lee W.R.; Senile atrophy of the human lacrimal gland: The contribution of chronic inflammatory disease. Br J Ophthalmol 1984,68(9),674-680","journal-title":"Br J Ophthalmol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","volume":"107","author":"Stevenson D.","year":"2000","unstructured":"Stevenson D.; Tauber J.; Reis B.L.; Group C.A.P.S.; Cyclosporin A.; Phase 2 Study Group. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial. Ophthalmology 2000,107(5),967-974","journal-title":"Ophthalmology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"Pflugfelder S.C.","year":"2004","unstructured":"Pflugfelder S.C.; Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004,137(2),337-342","journal-title":"Am J Ophthalmol"},{"key":"ref=59","first-page":"2346","volume":"53","author":"Kaja S.","year":"2012","unstructured":"Kaja S.; Koulen P.; Antioxidants restore lacrimal gland function through a calcium-mediated mechanism in experimental models of dry-eye disease. Invest Ophthalmol Vis Sci 2012,53(14),2346","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=60","first-page":"1966","volume":"18","author":"Chung S.H.","year":"2012","unstructured":"Chung S.H.; Choi S.H.; Choi J.A.; Chuck R.S.; Joo C.K.; Curcumin suppresses ovalbumin-induced allergic conjunctivitis. Mol Vis 2012,18,1966-1972","journal-title":"Mol Vis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.exer.2009.12.004","volume":"90","author":"Chen M.","year":"2010","unstructured":"Chen M.; Hu D.N.; Pan Z.; Lu C.W.; Xue C.Y.; Aass I.; Curcumin protects against hyperosmoticity-induced IL-1&#x3B2; elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res 2010,90(3),437-443","journal-title":"Exp Eye Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/ph13100295","volume":"13","author":"Muz O.E.","year":"2020","unstructured":"Muz O.E.; Orhan C.; Erten F.; Tuzcu M.; Ozercan I.H.; Singh P.; Morde A.; Padigaru M.; Rai D.; Sahin K.; A novel integrated active herbal formulation ameliorates dry eye syndrome by inhibiting inflammation and oxidative stress and enhancing glycosylated phosphoproteins in rats. Pharmaceuticals (Basel) 2020,13(10),295","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"Anand P.","year":"2007","unstructured":"Anand P.; Kunnumakkara A.B.; Newman R.A.; Aggarwal B.B.; Bioavailability of curcumin: Problems and promises. Mol Pharm 2007,4(6),807-818","journal-title":"Mol Pharm"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.hermed.2015.03.001","volume":"5","author":"Siviero A.","year":"2015","unstructured":"Siviero A.; Gallo E.; Maggini V.; Gori L.; Mugelli A.; Firenzuoli F.; Vannacci A.; Curcumin, a golden spice with a low bioavailability. J Herb Med 2015,5(2),57-70","journal-title":"J Herb Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jps.22785","volume":"101","author":"Basnet P.","year":"2012","unstructured":"Basnet P.; Hussain H.; Tho I.; Skalko-Basnet N.; Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci 2012,101(2),598-609","journal-title":"J Pharm Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/cncr.21300","volume":"104","author":"Li L.","year":"2005","unstructured":"Li L.; Braiteh F.S.; Kurzrock R.; Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005,104(6),1322-1331","journal-title":"Cancer"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1021\/jf100135h","volume":"58","author":"Yen F.L.","year":"2010","unstructured":"Yen F.L.; Wu T.H.; Tzeng C.W.; Lin L.T.; Lin C.C.; Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. J Agric Food Chem 2010,58(12),7376-7382","journal-title":"J Agric Food Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/jf104402t","volume":"59","author":"Bhawana B.R.","year":"2011","unstructured":"Bhawana B.R.; Basniwal R.K.; Buttar H.S.; Jain V.K.; Jain N.; Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem 2011,59(5),2056-2061","journal-title":"J Agric Food Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1002\/jcb.28068","volume":"120","author":"Farajipour H.","year":"2018","unstructured":"Farajipour H.; Rahimian S.; Taghizadeh M.; Curcumin: A new candidate for retinal disease therapy? J Cell Biochem 2018,120(5),6886-6893","journal-title":"J Cell Biochem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/ijmm.2021.4908","volume":"47","author":"Yang J.","year":"2021","unstructured":"Yang J.; Miao X.; Yang F.J.; Cao J.F.; Liu X.; Fu J.L.; Su G.F.; Therapeutic potential of curcumin in diabetic retinopathy (Review). Int J Mol Med 2021,47(5),75","journal-title":"Int J Mol Med"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220609085614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205751\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220609085614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:13:49Z","timestamp":1683112429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205751\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201023666220609085614","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}